The Taibo® Sildenafil Citrate Orally Disintegrating Tablets (50mg), which is our company's new dosage form and deemed to have passed the consistency evaluation, was recently approved for marketing.
MoreThe new warehouse with an investment of 22 million yuan, located east of its Nanjing Pharmaceutical Factory, is expected to open in February 2008.
MoreC&O is pleased to be appointed by Shantou Meiji Pharmaceutical Co., Ltd., a subsidiary of Tokyo-listed Meiji Seika Kaisha, Ltd. (“Meiji Seika Kaisha”), as the distributor of its new-generation cephalosporin, Meiact.
More